cetylpyridinium chloride anhydrous has been researched along with Granulomatosis with Polyangiitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boissier, MC; Boyer, N; Chanseaud, Y; Guillevin, L; Guilpain, P; Kambouchner, M; Mouthon, L; Noël, LH; Reinbolt, J; Tamby, MC | 1 |
| Cotch, MF; Drucker, Y; Easley, K; Hoffman, GS; Kwoh, K; Locker, GA | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Granulomatosis with Polyangiitis
| Article | Year |
|---|---|
Analysis of autoantibody repertoires in small- and medium-sized vessels vasculitides. Evidence for specific perturbations in polyarteritis nodosa, microscopic polyangiitis, Churg-Strauss syndrome and Wegener's granulomatosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antigens; Autoantibodies; Case-Control Studies; Churg-Strauss Syndrome; Female; Granulomatosis with Polyangiitis; Health; Humans; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Molecular Weight; Polyarteritis Nodosa; Vasculitis | 2005 |
Wegener's granulomatosis: patient-reported effects of disease on health, function, and income.
Topics: Granulomatosis with Polyangiitis; Health; Humans; Income; Quality of Life; Surveys and Questionnaires | 1998 |